ProShare Advisors LLC - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 278 filers reported holding BLUEPRINT MEDICINES CORP in Q4 2020. The put-call ratio across all filers is 4.17 and the average weighting 0.2%.

Quarter-by-quarter ownership
ProShare Advisors LLC ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q3 2023$595,861
-20.2%
11,865
+0.4%
0.00%0.0%
Q2 2023$747,087
+48.4%
11,821
+5.6%
0.00%0.0%
Q1 2023$503,528
-15.1%
11,192
-17.4%
0.00%0.0%
Q4 2022$593,363
-28.3%
13,544
+7.9%
0.00%
-33.3%
Q3 2022$828,000
+33.1%
12,554
+1.8%
0.00%
+50.0%
Q2 2022$622,000
-47.2%
12,330
-33.2%
0.00%
-33.3%
Q1 2022$1,179,000
-51.2%
18,452
-18.1%
0.00%
-40.0%
Q4 2021$2,415,000
+9.8%
22,541
+5.3%
0.01%
-16.7%
Q3 2021$2,200,000
-9.9%
21,398
-23.0%
0.01%
-14.3%
Q2 2021$2,443,000
+5.2%
27,772
+16.3%
0.01%0.0%
Q1 2021$2,323,000
-5.3%
23,889
+9.3%
0.01%
-22.2%
Q4 2020$2,452,000
+58.9%
21,861
+31.3%
0.01%
+28.6%
Q3 2020$1,543,000
+17.0%
16,645
-1.6%
0.01%0.0%
Q2 2020$1,319,000
+109.0%
16,908
+56.8%
0.01%
+40.0%
Q1 2020$631,000
-57.3%
10,783
-41.5%
0.01%
-28.6%
Q4 2019$1,477,000
+0.5%
18,437
-7.9%
0.01%
-12.5%
Q3 2019$1,470,000
-18.2%
20,014
+5.1%
0.01%
-27.3%
Q2 2019$1,796,000
+15.2%
19,041
-2.2%
0.01%
+22.2%
Q1 2019$1,559,000
+50.2%
19,477
+1.2%
0.01%
+28.6%
Q4 2018$1,038,000
-42.1%
19,251
-16.1%
0.01%
-41.7%
Q3 2018$1,792,000
+18.3%
22,955
-3.8%
0.01%
+20.0%
Q2 2018$1,515,000
-35.6%
23,871
-6.9%
0.01%
-33.3%
Q1 2018$2,351,000
+13.6%
25,643
-6.5%
0.02%
+7.1%
Q4 2017$2,069,000
+20.2%
27,435
+11.1%
0.01%
-12.5%
Q3 2017$1,721,000
+44.7%
24,704
+5.3%
0.02%
+33.3%
Q2 2017$1,189,000
+45.4%
23,460
+14.7%
0.01%
+33.3%
Q1 2017$818,000
+37.0%
20,460
-3.8%
0.01%
+28.6%
Q4 2016$597,000
+4.7%
21,268
+10.9%
0.01%
-12.5%
Q3 2016$570,000
+23.9%
19,180
-15.6%
0.01%
+33.3%
Q2 2016$460,000
+20.1%
22,726
+7.2%
0.01%
+20.0%
Q1 2016$383,000
-37.2%
21,206
-8.4%
0.01%
-28.6%
Q4 2015$610,00023,1570.01%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q4 2020
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 379,090$19,037,90017.25%
DAFNA Capital Management LLC 249,521$12,530,9453.90%
Rock Springs Capital Management LP 2,685,294$134,855,4653.61%
Casdin Capital, LLC 371,378$18,650,6032.06%
Novo Holdings A/S 525,000$26,365,5001.95%
CHI Advisors LLC 92,888$4,664,8351.85%
SECTORAL ASSET MANAGEMENT INC 165,890$8,330,9961.62%
Avidity Partners Management LP 751,600$37,745,3521.52%
EMERALD ADVISERS, LLC 607,037$30,485,3931.48%
EMERALD MUTUAL FUND ADVISERS TRUST 464,321$23,318,2011.41%
View complete list of BLUEPRINT MEDICINES CORP shareholders